Prio Wealth Limited Partnership’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-764
| Closed | -$216K | – | 273 |
|
|
2021
Q3 | $216K | Hold |
764
| – | – | 0.01% | 262 |
|
|
2021
Q2 | $265K | Buy |
+764
| New | +$231K | 0.01% | 247 |
|
|
2020
Q2 | – | Sell |
-640
| Closed | -$202K | – | 253 |
|
|
2020
Q1 | $202K | Sell |
640
-34
| -5% | -$10.3K | 0.01% | 226 |
|
|
2019
Q4 | $200K | Buy |
+674
| New | +$187K | 0.01% | 255 |
|
|
2019
Q1 | – | Sell |
-737
| Closed | -$221K | – | 240 |
|
|
2018
Q4 | $221K | Buy |
737
+100
| +16% | +$31.9K | 0.01% | 210 |
|
|
2018
Q3 | $225K | Sell |
637
-194
| -23% | -$66.8K | 0.01% | 226 |
|
|
2018
Q2 | $241K | Buy |
831
+2
| +0.2% | +$562 | 0.01% | 221 |
|
|
2018
Q1 | $226K | Sell |
829
-14
| -2% | -$4.35K | 0.01% | 224 |
|
|
2017
Q4 | $268K | Hold |
843
| – | – | 0.01% | 210 |
|
|
2017
Q3 | $263K | Hold |
843
| – | – | 0.01% | 209 |
|
|
2017
Q2 | $228K | Buy |
+843
| New | +$223K | 0.01% | 225 |
|
|
2016
Q4 | – | Sell |
-1,360
| Closed | -$425K | – | 241 |
|
|
2016
Q3 | $425K | Hold |
1,360
| – | – | 0.02% | 184 |
|
|
2016
Q2 | $328K | Hold |
1,360
| – | – | 0.02% | 202 |
|
|
2016
Q1 | $354K | Buy |
1,360
+5
| +0.4% | +$1.32K | 0.02% | 191 |
|
|
2015
Q4 | $415K | Hold |
1,355
| – | – | 0.02% | 186 |
|
|
2015
Q3 | $395K | Hold |
1,355
| – | – | 0.02% | 189 |
|
|
2015
Q2 | $547K | Buy |
1,355
+20
| +1% | +$8.03K | 0.03% | 174 |
|
|
2015
Q1 | $563K | Hold |
1,335
| – | – | 0.03% | 175 |
|
|
2014
Q4 | $453K | Buy |
1,335
+20
| +2% | +$6.47K | 0.02% | 183 |
|
|
2014
Q3 | $435K | Sell |
1,315
-25
| -2% | -$8.24K | 0.02% | 182 |
|
|
2014
Q2 | $422K | Buy |
1,340
+20
| +2% | +$6.02K | 0.02% | 189 |
|
|
2014
Q1 | $403K | Sell |
1,320
-55
| -4% | -$17.5K | 0.02% | 191 |
|
|
2013
Q4 | $384K | Buy |
1,375
+120
| +10% | +$31K | 0.02% | 194 |
|
|
2013
Q3 | $302K | Hold |
1,255
| – | – | 0.02% | 210 |
|
|
2013
Q2 | $270K | Buy |
+1,255
| New | +$268K | 0.02% | 214 |
|